Eyebot

Eyebot is an outcome-focused technology company on a mission to make vision care accessible to everyone, equally. Headquartered in Boston’s North End and backed by top investors and the National Science Foundation, their 90-second vision test kiosk is reshaping how vision care is delivered.

Eyebot raised $20M in a Series A round announced August 26, 2025, according to techcrunch.com. Investors in that round: General Catalyst.

Raise history

1. September 29, 2026
   First seen by Recent Funding
   via startups.gallery
2. August 26, 2025
   Series A · $20M
   GGeneral Catalyst (lead)
   Source: techcrunch.com (startups.gallery listing)

Investors

• AAlleyCorp
• GGeneral Catalyst
• VVillage Global

Related other companies

• QQuartermaster$140M · Sep 28, 2026
• SSnorkel AI$350M · Sep 23, 2026
• EEnveda$311M · Sep 23, 2026
• HHeidi Health$100M · Sep 22, 2026
• FFirecrawl$75M · Sep 22, 2026
• CCorridor$25M · Sep 21, 2026
• JJack & Jill$40M · Sep 19, 2026
• MMithr Inc.$20M · Sep 19, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/eyebot.